Unlike the dopplegängers of folklore or the evil twins of popular entertainment, digital twins don’t just appear seemingly out of nowhere. They are painstakingly developed and refined. And neither are ...
Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...
Technical Report No. 56 (Revised 2026) outlines a GMP--compliant, phase--appropriate quality management system (QMS) spanning preclinical development through clinical phases and commercial readiness ...
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...
Drug developers are seeking to speed up the testing and developing of new drugs with the help of artificial intelligence (AI). Researchers at universities and pharmaceutical giants are testing how AI ...
The tech giant’s new AI platform aims to make drug discovery faster and cleaner.
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
The U.S. Food and Drug Administration (FDA) announced a new process called “Rare Disease Evidence Principles” (RDEP), under which eligible drugs and biologics for ultra-rare diseases caused by known ...
UAE Develops First AI-Discovered Drug Candidate In Less Than 12 Months . The compound demonstrates promising potential in targeting solid tumours, particularly aggressive brain cancers By: Yasmin Hu ...
(CNN) — The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
Hosted on MSN
FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs
The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results